MIM
IMGN

Macroview Investment Management’s Immunogen Inc IMGN Stock Holding History

Macroview Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-162
Closed -$4.8K – 718
2023
Q4 		$4.8K Sell
162
-531
-77% -$10.6K 0.01% 411
2023
Q3 		$11K Buy
+693
New +$11.5K 0.01% 230
2022
Q1 		– Sell
-2,463
Closed -$18K – 503
2021
Q4 		$18K Buy
+2,463
New +$15.3K 0.02% 189

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Macroview Investment Management's IMGN Position: Q1 2024 in Review

Macroview Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 162 shares — an estimated $4.8K sold.

Macroview Investment Management first reported a position in IMGN in Q4 2021 and held it in 3 quarters. The position peaked at $18K in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Macroview Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Macroview Investment Management sold 162 Immunogen Inc shares in Q1 2024, an estimated $4.8K.
  • Macroview Investment Management first reported a position in Immunogen Inc in Q4 2021 and held it in 3 quarters.
  • Macroview Investment Management's Immunogen Inc position peaked at $18K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Macroview Investment Management's 13F filing for Q1 2024, filed 30 Apr 2024.